BioVie Inc.
BIVI
$1.46
$0.053.55%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 8.19M | 8.79M | 8.57M | 8.87M | 9.26M |
| Depreciation & Amortization | 229.20K | 229.20K | 229.20K | 229.20K | 229.20K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 18.20M | 19.23M | 18.07M | 19.19M | 23.94M |
| Operating Income | -18.20M | -19.23M | -18.07M | -19.19M | -23.94M |
| Income Before Tax | -17.43M | -18.48M | -17.54M | -18.99M | -24.27M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -17.43 | -18.48 | -17.54 | -18.99 | -24.27 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -17.43M | -18.48M | -17.54M | -18.99M | -24.27M |
| EBIT | -18.20M | -19.23M | -18.07M | -19.19M | -23.94M |
| EBITDA | -17.97M | -19.00M | -17.84M | -18.96M | -23.71M |
| EPS Basic | -5.13 | -8.92 | -14.94 | -21.14 | -39.62 |
| Normalized Basic EPS | -3.20 | -5.55 | -9.00 | -12.88 | -23.19 |
| EPS Diluted | -5.14 | -8.92 | -14.94 | -21.14 | -39.64 |
| Normalized Diluted EPS | -3.20 | -5.55 | -9.00 | -12.88 | -23.19 |
| Average Basic Shares Outstanding | 16.84M | 10.50M | 5.92M | 4.67M | 3.27M |
| Average Diluted Shares Outstanding | 16.84M | 10.50M | 5.92M | 4.67M | 3.27M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |